Overview - XLRN US

Acceleron Pharma Inc

XLRN.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. It offers REBLOZYL (luspatercept-aamt), a first-in-class erythroid maturation agent, for the treatment of anemia in adult patients with beta-thalassemia and transfusion-dependent anemia. The company is also developing Sotatercept, an activin receptor type IIA fusion protein, for the treatment of patients with pulmonary arterial hypertension; ACE-1334, a pulmonary therapeutic candidate that is in Phase I clinical trials; and luspatercept-aamt for non-transfusion-dependent beta-thalassemia patients and lower-risk myelodysplastic syndrome patients. It has a license agreements with the Salk Institute for Biological Studies for the cloning of type II activin receptors; and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. As of November 19, 2021, Acceleron Pharma Inc. operates as a subsidiary of Merck Sharp & Dohme Corp.

symbol	last	change	%chng	name	mcap	sector	wiki
XLRN				Acceleron Pharma Inc	10.932B	Healthcare	wiki y

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
D	XLRN	0.00	0,-3.690,-5.000,-2.134,-3.690	178.75	44.50-99.23		267,935,267	-22.3	Oct 5-Jun 29	29.11%

Intraday chart for XLRN

Please reload the page if latest figures not showing

News for XLRN

headline news | recent news | latest news | market news

Chart XLRN

Similar stocks g.biopharmaceutical

Seagen Inc	SGEN	US	Healthcare	30.4971	43155M	-
Acceleron Pharma Inc	XLRN	US	Healthcare	53.5935	10932M	-
Ligand Pharmaceuticals Incorporated	LGND	US	Healthcare	39.4475	1294M	-
Intercept Pharmaceuticals Inc	ICPT	US	Healthcare	60.1151	795M	-
Aerie Pharmace	AERI	US	Healthcare	49.9191	754M	-
Flexion Therapeutics Inc	FLXN	US	Healthcare	33.9944	459M	-
Tekla Life Sciences Investors	HQL	US	Financial Services	25.6617	356M	-
Adverum Biotechnologies Inc	ADVM	US	Healthcare	24.2964	291M	-
ZIOPHARM Oncology Inc	ZIOP	US	Healthcare	20.0926	187M	-
Assembly Biosciences Inc	ASMB	US	Healthcare	21.5176	81M	-

Myshare aims to provide good clear honest and easy analysis of financial markets using a scientific, teaching and informative approach. We try hard but please read our disclaimer. Pages are provided by ourselves and our users. Register to edit pages and see the documentation

Global news | headline news | recent news | latest news | market news | topics | stock topics

News topics and stories from around the world and in the selected country

US News | headline news | recent news | latest news | market news | recent topics | stock topics

News from major news outlets like BBC, CNN and Reuters

Forecasts | Forecast buy | Forecast sell | Forecast up | Forecast down | Forecast sector

Long term stock predictions using AI reading the financial accounts of each company.

``` ``` ``` ```